Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression
Abstract
Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.
Related
- Apigenin Attenuates Lipopolysaccharide-Induced Endothelial Activation and Injury-Associated Phenotypes in Human Umbilical Vein Endothelial Cells
- hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro
- Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes
- Small-molecule ACOD1 inhibition attenuates colitis and tumor growth through a shared myeloid mechanism, diverging from genetic deletion
- Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS‐Induced Colitis via Mucus Barrier Protection
BibTeX
@article{garciasanchez2026delta8tetrahydrocannabinol,
title = {{Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression}},
author = {Jeffrey I. Garcia-Sanchez and Taylor H. Carter and Urmi Halder and Mitzi Nagarkatti and Prakash Nagarkatti},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.1973874},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression
AU - Jeffrey I. Garcia-Sanchez
AU - Taylor H. Carter
AU - Urmi Halder
AU - Mitzi Nagarkatti
AU - Prakash Nagarkatti
PY - 2026
DA - 2026/11/13
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1973874
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874
AB - Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.
SN - 1663-9812
ER -